Related Experiment Videos
Search for Novel Antibacterial Compounds and Targets
1Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University.
Abstract:
Drug-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Pseudomonas aeruginosa, and vancomycin-resistant enterococci (VRE) have been spreading; however, the development of new antibacterial drugs has not progressed accordingly. Novel antibacterial drugs or their candidate seeds need to be developed for effective antibiotic therapy. Under these conditions, the search for novel compounds and novel targets is important. In Okayama University, as a part of the Drug Discovery for Intractable Infectious Diseases project, we are proceeding with the development of antibacterial drugs for the treatment of drug-resistant bacterial infections. We found that riccardin C (a natural product of liverwort) and 6,6'-dihydroxythiobinupharidine (from the crude drug Senkotsu) exhibited strong antibacterial activities, particularly against Gram-positive bacteria. We showed that riccardin C induced cell membrane leakage and that 6,6'-dihydroxythiobinupharidine inhibited DNA topoisomerase IV. Moreover, 6,6'-dihydroxythiobinupharidine exerted synergistic effects with already known anti-MRSA drugs as well as with vancomycin for VRE.
Insights
Novel compounds riccardin C and 6,6'-dihydroxythiobinupharidine show potent antibacterial activity against drug-resistant bacteria. Riccardin C disrupts cell membranes, while 6,6'-dihydroxythiobinupharidine inhibits DNA topoisomerase IV, offering new hope for antibiotic therapy.
Area of Science:
- Natural Product Chemistry
- Microbiology
- Drug Discovery
Background:
- Rising prevalence of multidrug-resistant bacteria like MRSA, Pseudomonas aeruginosa, and VRE necessitates new antibacterial agents.
- Limited progress in developing novel antibiotics hinders effective treatment of resistant infections.
- Identification of novel compounds and molecular targets is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To discover and characterize novel antibacterial compounds from natural sources.
- To investigate the mechanisms of action for identified antibacterial agents.
- To evaluate the potential of these compounds in treating drug-resistant bacterial infections.
Main Methods:
- Screening of natural products for antibacterial activity.
- Chemical isolation and structural elucidation of active compounds.
- Assays to determine mechanisms of action, including cell membrane integrity and enzyme inhibition (DNA topoisomerase IV).
- Evaluation of synergistic effects with existing antibiotics.
Main Results:
- Riccardin C (from liverwort) and 6,6 -dihydroxythiobinupharidine (from Senkotsu) demonstrated significant antibacterial activity, especially against Gram-positive bacteria.
- Riccardin C was found to induce cell membrane leakage.
- 6,6 -dihydroxythiobinupharidine inhibited DNA topoisomerase IV and showed synergistic effects with anti-MRSA drugs and vancomycin against VRE.
Conclusions:
- Riccardin C and 6,6 -dihydroxythiobinupharidine represent promising leads for developing new antibacterial drugs.
- The distinct mechanisms of action (membrane disruption and topoisomerase inhibition) offer potential for novel therapeutic strategies.
- Synergistic potential highlights the possibility of combination therapies to overcome existing resistance.